{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:30:02Z","timestamp":1769146202309,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,9,26]],"date-time":"2014-09-26T00:00:00Z","timestamp":1411689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10719-014-9559-1","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T07:55:21Z","timestamp":1411631721000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Roberto","family":"Adamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Nilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Harfouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Brogioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Pecetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Brogioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evita","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Tontini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,26]]},"reference":[{"key":"9559_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-030409-101159","volume":"28","author":"FY Avci","year":"2010","unstructured":"Avci, F.Y., Kasper, D.L.: How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 28, 107\u2013110 (2010)","journal-title":"Annu Rev Immunol"},{"key":"9559_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14712598.2012.725718","volume":"13","author":"D Pace","year":"2013","unstructured":"Pace, D.: Glycoconjugate vaccines. Expert Opin Biol Ther 13, 11\u201333 (2013)","journal-title":"Expert Opin Biol Ther"},{"key":"9559_CR3","doi-asserted-by":"crossref","unstructured":"Calix. J.J. Porambo, R.J. Brady A.M. Larson. T.R. Yother J. Abeygunwardana C. Nahm M.H. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J. Biol. Chem., 27885\u201327894 (2012)","DOI":"10.1074\/jbc.M112.380451"},{"key":"9559_CR4","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","volume":"6","author":"I Delrieu","year":"2011","unstructured":"Delrieu, I., Yaro, S., Tamekloe, T.A., Njanpop-Lafourcade, B.M., Tall, H., Jaillard, P., Quedraogo, M.S., Badziclou, K., Sanou, O., Drabo, A., Gessner, B.D., Kambou, J.L., Mueller, J.E.: Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS One 6, e19513 (2011)","journal-title":"PLoS One"},{"key":"9559_CR5","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/c3sc50862e","volume":"4","author":"R Adamo","year":"2013","unstructured":"Adamo, R., Nilo, A., Castagner, B., Boutureira, O., Berti, F., Bernardes, G.J.L.: Synthetically defined glycoprotein vaccines: current status & future directions. Chem Sci 4, 2995\u20133008 (2013)","journal-title":"Chem Sci"},{"key":"9559_CR6","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.vaccine.2008.01.022","volume":"26","author":"A Bardotti","year":"2009","unstructured":"Bardotti, A., Averani, G., Berti, F., Berti, S., Carinci, V., D\u2019Ascenzi, S., Fabbri, B., Giannini, S., Giannozzi, A., Magagnoli, C., Proietti, D., Norelli, F., Rappuoli, R., Ricci, S., Costantino, P.: Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases. Vaccine 26, 2284\u20132296 (2009)","journal-title":"Vaccine"},{"key":"9559_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0161-5890(86)90136-7","volume":"23","author":"M Porro","year":"1986","unstructured":"Porro, M., Costantino, P., Giovannoni, F., Pellegrini, V., Tagliaferri, L., Vannozzi, F., Viti, S.: A molecular model of artificial glycoprotein with predetermined multiple immunodeterminants for gram-positive and gram-negative encapsulated bacteria. Mol Immunol 23, 385\u2013391 (1986)","journal-title":"Mol Immunol"},{"key":"9559_CR8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10719-009-9259-4","volume":"27","author":"AFG Bongat","year":"2010","unstructured":"Bongat, A.F.G., Saksena, R., Adamo, R., Fujimoto, Y., Shiokawa, Z., Peterson, D.C., Fukase, K., Vann, W.F., Kov\u00e1\u010d, P.: Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant. Glycoconj J 27, 69\u201377 (2010)","journal-title":"Glycoconj J"},{"key":"9559_CR9","first-page":"4116","volume":"190","author":"T Lipinski","year":"2013","unstructured":"Lipinski, T., Fitieh, A., St Pierre, J., Ostergaard, H.L., Bundle, D.R., Toure, N.: Enhanced immunogenicity of a tricomponent mannan tetanus Toxoid conjugate vaccine targeted to dendritic cells via dectin-1 by incorporating \u03b2 glucan. J Infect Dis 190, 4116\u20134128 (2013)","journal-title":"J Infect Dis"},{"key":"9559_CR10","doi-asserted-by":"crossref","unstructured":"Buskas, T., Thompson, P., Boons, G.-J.: Immunotherapy for cancer: synthetic carbohydrate-based vaccines. Chem. Comm., 5335\u20135349 (2009).","DOI":"10.1039\/b908664c"},{"key":"9559_CR11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nchembio.2007.25","volume":"3","author":"S Ingale","year":"2007","unstructured":"Ingale, S., Wolfert, M.A., Gaekwad, J., Buskas, T., Boons, G.-J.: Robust immune responses elicited by a fully synthetic three-component vaccine. Nat Chem Biol 3, 663\u2013667 (2007)","journal-title":"Nat Chem Biol"},{"key":"9559_CR12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00262-004-0598-5","volume":"54","author":"SF Slovin","year":"2005","unstructured":"Slovin, S.F., Ragupathi, G., Musselli, C., Fernandez, C., Diani, M., Verbel, D., Danishefsky, S., Livingston, P., Scher, H.: Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer. Cancer Immunol Immunother 54, 694\u2013702 (2005)","journal-title":"Cancer Immunol Immunother"},{"key":"9559_CR13","first-page":"367","volume":"6","author":"AJ Sant","year":"2007","unstructured":"Sant, A.J., Chaves, F.A., Krafcic, F.R., Lazarski, C.A., Menges, P., Richards, K., Weaver, J.M.: Immunodominance in CD4 T-cells response: implcations for immune responses to influenza virus for vaccine design. Expert Rev Vaccines 6, 367\u2013368 (2007)","journal-title":"Expert Rev Vaccines"},{"key":"9559_CR14","doi-asserted-by":"crossref","unstructured":"Chen, W., McCluskey, J. Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8 T-Cell\u2013Based Cancer Vaccines. Advances in Cancer Research, 203\u2013248 (2006).","DOI":"10.1016\/S0065-230X(06)95006-4"},{"key":"9559_CR15","unstructured":"Gotschlich, E.C.: Meningococcal meningitis. In: Bacteria\/ Vaccine. Ed. Germanier, R. Academic Press, New York, 237\u2013255 (1984)."},{"key":"9559_CR16","first-page":"114","volume":"28","author":"L Lapeyssonnie","year":"1963","unstructured":"Lapeyssonnie, L.: Bull. World. Health Organ 28, 114 (1963)","journal-title":"Health Organ"},{"key":"9559_CR17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.330.6010.1466","volume":"330","author":"L Roberts","year":"2010","unstructured":"Roberts, L.: Vaccine introduction. the beginning of the end for Africa's devastating meningitis outbreaks? Science 330, 1466\u20131467 (2010)","journal-title":"Science"},{"key":"9559_CR18","doi-asserted-by":"crossref","unstructured":"Clements, D.A., Gilbert, G.L.: Increase in admissions for Neisseria meningitidis infection in Australia. Lancet II, 1464 (1989).","DOI":"10.1016\/S0140-6736(89)92078-3"},{"key":"9559_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","volume":"50","author":"AC Cohn","year":"2010","unstructured":"Cohn, A.C., MacNeil, J.R., Harrison, L.H., Hatcher, C., Theodore, J., Schmidt, M., Pondo, T., Arnold, K.E., Baumbach, J., Bennett, N., Craig, A.S., Farley, M., Gershman, K., Petit, S., Lynfield, R., Reingold, A., Schaffner, W., Shutt, K.A., Zell, E.R., Mayer, L.W., Clark, T., Stephens, D., Messonnier, N.E.: Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease. Clin Infect Dis 50, 184\u2013191 (2010)","journal-title":"Clin Infect Dis"},{"key":"9559_CR20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3201\/13-0610","volume":"19","author":"DE Barroso","year":"2013","unstructured":"Barroso, D.E., Casti\u00f1eiras, T.M.P.P., Freitas, F.S., Marsh, J.W., Krauland, M.G., Tulenko, M.M., Fonseca, \u00c9.L., Vicente, A.C.P., Rebelo, M.C., Cerqueira, E.O., Xavier, A.C., Cardozo, A.P.C.M., da Silva, S.E.M., Harrison, L.H.: Three outbreakcausing Neisseria meningitidis serogroup C clones,Brazil. Emerg Infect Dis 19, 1847\u20131850 (2013)","journal-title":"Emerg Infect Dis"},{"key":"9559_CR21","unstructured":"not listed], N.a.: Menactra: a meningococcal conjugate vaccine. Med. Lett. Drugs Ther. 47, 29\u201331 (2005)."},{"key":"9559_CR22","unstructured":"not listed], N.a.: A new conjugate meningococcal vaccine (Menveo). Med. Lett. Drugs Ther. 52, 59\u201360 (2010)."},{"key":"9559_CR23","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","volume":"364","author":"SO Sow","year":"2011","unstructured":"Sow, S.O., Okoko, B.J., Diallo, A., Viviani, S., Borrow, R., Carlone, G., Tapia, M., Akinsola, A.K., Arduin, P., Findlow, H., Elie, C., Haidara, F.C., Adegbola, R.A., Diop, D., Parulekar, V., Chaumont, J., Martellet, L., Diallo, F., Idoko, O.T., Tang, Y., Plikaytis, B.D., Kulkarni, P.S., Marchetti, E., La Force, F.M., Preziosi, M.P.: Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans. N Engl J Med 364, 2293\u20132304 (2011)","journal-title":"N Engl J Med"},{"key":"9559_CR24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","volume":"10","author":"P Costantino","year":"1992","unstructured":"Costantino, P., Viti, S., Podda, A.M., Velmonte, A., Nencioni, L., Rappuoli, R.: Development and phase I clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 10, 691\u2013698 (1992)","journal-title":"Vaccine"},{"key":"9559_CR25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0264-410X(98)00348-X","volume":"17","author":"P Costantino","year":"1999","unstructured":"Costantino, P., Norelli, F., Giannozzi, A., D\u2019Ascenzi, S., Bartoloni, A., Kaurb, S., Tang, D., Seid, R., Viti, S., Paffetti, R., Bigio, M., Pennatini, C., Averani, G., Guarnieri, V., Gallo, E., Ravenscroft, N., Lazzeroni, C., Rappuoli, R., Ceccarini, C.: Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines. Vaccine 17, 1251\u20131263 (1999)","journal-title":"Vaccine"},{"key":"9559_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(88)90196-2","volume":"106","author":"RA Macdonald","year":"1988","unstructured":"Macdonald, R.A., Hosking, C.S., Jones, C.L.: The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Meth 106, 191\u2013194 (1988)","journal-title":"J Immunol Meth"},{"key":"9559_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","volume":"86","author":"GR Pullen","year":"1986","unstructured":"Pullen, G.R., Fitzgerald, M.G., Hosking, C.S.: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Meth 86, 83\u201387 (1986)","journal-title":"J Immunol Meth"},{"key":"9559_CR28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","volume":"73","author":"MM Giuliani","year":"2005","unstructured":"Giuliani, M.M., Santini, L., Brunelli, B., Biolchi, A., Aric\u00f2, B., Di Marcello, F., Cartocci, E., Comanducci, M., Masignani, V., Lozzi, L., Savino, S., Scarselli, M., Rappuoli, R., Pizza, M.: The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect Imm 73, 1151\u20131160 (2005)","journal-title":"Infect Imm"},{"key":"9559_CR29","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","volume":"190","author":"E Malito","year":"2012","unstructured":"Malito, E., Bursulaya, B., Chen, C., Lo Surdo, P., Picchianti, M., Balducci, E., Biancucci, M., Brock, A., Berti, F., Bottomley, M.J., Nissum, M., Costantino, P., Rappuoli, R., Spraggon, G.: Structural basis for lack of toxicity of the diphtheria toxin mutant. CRM197. Proc Natl Acad Sci U S A 190, 5229\u20135234 (2012)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9559_CR30","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cbic.201300785","volume":"15","author":"S Crotti","year":"2014","unstructured":"Crotti, S., Zhai, H., Zhou, J., Allan, M., Proietti, D., Pansegrau, W., Hu, Q.-Y., Berti, F., Adamo, R.: Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping. Chembiochem Europ J chem biol 15, 836\u2013843 (2014)","journal-title":"Chembiochem Europ J chem biol"},{"key":"9559_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jps.22759","volume":"101","author":"S Vecchi","year":"2012","unstructured":"Vecchi, S., Bufali, S., Skibinski, D.A.G., O\u2019Hagan, D.T., Singh, M.: Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations. J Pharm Sc 101, 17\u201320 (2012)","journal-title":"J Pharm Sc"},{"key":"9559_CR32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","volume":"17","author":"H Campbell","year":"2010","unstructured":"Campbell, H., Andrews, N., Borrow, R., Trotter, C., Miller, E.: Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol 17, 840\u2013847 (2010)","journal-title":"Clin Vaccine Immunol"},{"key":"9559_CR33","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2012.08.004","volume":"30","author":"S Hirve","year":"2012","unstructured":"Hirve, S., Bavdekar, A., Pandit, A., Juvekar, S., Patil, M., Preziosi, M.-P., Tang, Y., Marchetti, E., Martellet, L., Findlow, H., Elie, C., Parulekar, V., Plikaytis, B., Borrow, R., Carlone, G., Kulkarni, P.S., Goel, A., Suresh, K., Beri, S., Kapre, S., Jadhav, S., Preaud, J.-M., Viviani, S., LaForce, F.M.: Immunogenicity and safety of a new meningococcal a conjugate vaccine in Indian children aged 2\u201310 years: A Phase II\/III double-blind randomized controlled trial. Vaccine 30, 6456\u20136460 (2012)","journal-title":"Vaccine"},{"key":"9559_CR34","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1073\/pnas.1314476110","volume":"110","author":"F Micoli","year":"2013","unstructured":"Micoli, F., Romano, M.R., Tontini, M., Cappelletti, E., Gavinia, M., Proietti, D., Rondini, S., Swennen, E., Santini, L., Filippini, S., Balocchi, C., Adamo, R., Pluschke, G., Norheimd, G., Pollard, A., Saul, A., Rappuoli, R., MacLennan, C.A., Berti, F., Costantino, P.: Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X. Proc Natl Acad Sci U S A 110, 19077\u201319082 (2013)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9559_CR35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2249.1999.01077.x","volume":"118","author":"M Anttila","year":"1999","unstructured":"Anttila, M., Voutilainen, M., Ja\u00e8ntti, V., Eskola, J., Ka\u00e8ythy, H.: Contribution of serotype-speci\u00aec IgG concentration IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin Exp Immunol 118, 402\u2013407 (1999)","journal-title":"Clin Exp Immunol"},{"key":"9559_CR36","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.4049\/jimmunol.0900164","volume":"183","author":"AS McKee","year":"2009","unstructured":"McKee, A.S., Munks, M.W., MacLeod, M.K.L., Fleenor, C.J., Van Rooijen, N., Kappler, J.W., Marrack, P.: Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol 183, 4403\u20134414 (2009)","journal-title":"J Immunol"},{"key":"9559_CR37","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","volume":"31","author":"M Tontini","year":"2013","unstructured":"Tontini, M., Berti, F., Romano, M.R., Proietti, D., Zambonelli, C., Bottomley, M.J., De Gregorio, E., Del Giudice, G., Rappuoli, R., Costantino, P.: Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines. Vaccine 31, 4827\u20134833 (2013)","journal-title":"Vaccine"},{"key":"9559_CR38","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1158\/1078-0432.CCR-06-2189","volume":"13","author":"TA Gilewski","year":"2007","unstructured":"Gilewski, T.A., Ragupathi, G., Dickler, M., Powell, S., Bhuta, S., Panageas, K.R., Koganty, R., Chin-Eng, J., Hudis, C., Norton, L., Houghton, A.N., Livingston, P.O.: Clin Cancer Res 13, 2977\u20132985 (2007)","journal-title":"Clin Cancer Res"},{"key":"9559_CR39","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","volume":"28","author":"R Dagan","year":"2010","unstructured":"Dagan, R., Poolman, J., Siegrist, C.A.: Glycoconjugate vaccines and immune interference: a review. Vaccine 28, 5513\u20135523 (2010)","journal-title":"Vaccine"},{"key":"9559_CR40","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","volume":"27","author":"EM Pollabauer","year":"2009","unstructured":"Pollabauer, E.M., Petermann, R., Ehrlich, H.J.: The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants. Vaccine 27, 1674\u20131679 (2009)","journal-title":"Vaccine"},{"key":"9559_CR41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/IAI.61.2.432-438.1993","volume":"61","author":"T Barington","year":"1991","unstructured":"Barington, T., Skettrup, M., Juul, L., Heilmann, C.: Non-epitope specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccine by preimmunization with vaccine components. Infect Imm 61, 432\u2013438 (1991)","journal-title":"Infect Imm"},{"key":"9559_CR42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.1994.03520140046036","volume":"272","author":"DM Granoff","year":"1994","unstructured":"Granoff, D.M., Holmes, S.J., Belshe, R.B., Osterholm, M.T., McHugh, J.E., Anderson, E.L.: Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. J Am Med Assoc 272, 1116\u20131121 (1994)","journal-title":"J Am Med Assoc"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-014-9559-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10719-014-9559-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-014-9559-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T22:53:54Z","timestamp":1598309634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10719-014-9559-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,26]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9559"],"URL":"https:\/\/doi.org\/10.1007\/s10719-014-9559-1","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,26]]}}}